Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2026-03-27 @ 7:53 AM
Study NCT ID:
NCT00972933
Status:
COMPLETED
Last Update Posted:
2017-12-07
First Post:
2009-09-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma
Sponsor:
Diwakar Davar
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
08-144
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |